GB1485738A - Ergot alkaloids - Google Patents

Ergot alkaloids

Info

Publication number
GB1485738A
GB1485738A GB3262675A GB3262675A GB1485738A GB 1485738 A GB1485738 A GB 1485738A GB 3262675 A GB3262675 A GB 3262675A GB 3262675 A GB3262675 A GB 3262675A GB 1485738 A GB1485738 A GB 1485738A
Authority
GB
United Kingdom
Prior art keywords
ergot alkaloids
ergot
alkaloids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3262675A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmaceutici Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia SpA filed Critical Farmaceutici Italia SpA
Priority to GB3262675A priority Critical patent/GB1485738A/en
Publication of GB1485738A publication Critical patent/GB1485738A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
GB3262675A 1976-08-02 1976-08-02 Ergot alkaloids Expired GB1485738A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB3262675A GB1485738A (en) 1976-08-02 1976-08-02 Ergot alkaloids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3262675A GB1485738A (en) 1976-08-02 1976-08-02 Ergot alkaloids

Publications (1)

Publication Number Publication Date
GB1485738A true GB1485738A (en) 1977-09-14

Family

ID=10341563

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3262675A Expired GB1485738A (en) 1976-08-02 1976-08-02 Ergot alkaloids

Country Status (1)

Country Link
GB (1) GB1485738A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8592445B2 (en) 2011-12-19 2013-11-26 Map Pharmaceuticals, Inc. Iso-ergoline derivatives
US8604035B2 (en) 2011-06-23 2013-12-10 Map Pharmaceuticals, Inc. Fluoroergoline analogs
US8710092B2 (en) 2009-12-23 2014-04-29 Map Pharmaceuticals, Inc. Substituted indolo 4,3 FG quinolines useful for treating migraine
US8946420B2 (en) 2011-12-21 2015-02-03 Map Pharmaceuticals, Inc. Neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8710092B2 (en) 2009-12-23 2014-04-29 Map Pharmaceuticals, Inc. Substituted indolo 4,3 FG quinolines useful for treating migraine
US8604035B2 (en) 2011-06-23 2013-12-10 Map Pharmaceuticals, Inc. Fluoroergoline analogs
US8927567B2 (en) 2011-06-23 2015-01-06 Map Pharceuticals, Inc. Fluoroergoline analogs
US8933093B2 (en) 2011-06-23 2015-01-13 Map Pharmaceuticals, Inc. Fluoroergoline analogs
US9150593B2 (en) 2011-06-23 2015-10-06 Map Pharmaceuticals, Inc. Fluoroergoline analogs
US9365591B2 (en) 2011-06-23 2016-06-14 Map Pharmaceuticals, Inc. Fluoroergoline analogs
US8592445B2 (en) 2011-12-19 2013-11-26 Map Pharmaceuticals, Inc. Iso-ergoline derivatives
US8722699B2 (en) 2011-12-19 2014-05-13 Map Pharmaceuticals, Inc. Iso-ergoline derivatives
US8969374B2 (en) 2011-12-19 2015-03-03 Map Pharmaceuticals, Inc. Iso-ergoline derivatives
US8946420B2 (en) 2011-12-21 2015-02-03 Map Pharmaceuticals, Inc. Neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives

Similar Documents

Publication Publication Date Title
ZA772752B (en) Novel tetracyclic derivatives
GB1541547A (en) 4-phenoxymethylpiperidine derivatives
GB1521020A (en) 4-hydrox-aporphine derivatives
JPS52139397A (en) Range tracer
YU40172B (en) Prcess for obtaining 7-substituted aminoacetamido-oxadethiacephalosporins
PH12202A (en) Ergot derivative
GB1543124A (en) 2-iminothiazolidine derivatives
AU3281078A (en) Ergot derivatives
GB1485738A (en) Ergot alkaloids
GB1553222A (en) 14 - hydroxy 3- eoxycardenolides
JPS5371100A (en) Oxazolidinedion derivative of nichinichi alkaloid
GB1553759A (en) Tetrahyddropyridine derivatives
GB1555751A (en) Ergoline deritatives
AU506218B2 (en) Ergot alkaloids
AU513821B2 (en) Ergoline derivatives
NZ189422A (en) Ergot peptide alkaloids
AU2281977A (en) Ergoline derivatives
JPS5289686A (en) Alkaloid derivatives
JPS5283898A (en) Novel ergoline derivatives
GB1549755A (en) N-4-halobutyryl derivatives
GB1523198A (en) Thiazolo-rifamycin derivatives
ZA777174B (en) Ergoline derivatives
AU2103877A (en) Ergot alkaloid derivatives
JPS5259922A (en) Waterproofed structure
GB1524481A (en) Tetrahydo - imidazopyridine derivatives

Legal Events

Date Code Title Description
PS Patent sealed
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee